Form 4 for OMDA Omada Health, Inc.
Accepted 2026-09-14 17:13:39 ET · period of report 2026-09-10 · accession 0001610717-26-000417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-14 17:13 | 2026-09-10 | OMDA | Duffy Sean P. | CEO, Dir | S - Sale | $21.87 | -15.0K | 382.6K | -4% | -$327.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-10 | S | D | 13,560 | $21.80 | 383,994 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $21.38 to $22.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2026-09-10 | S | D | 1,400 | $22.59 | 382,594 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F3) This transaction was executed in multiple trades at prices ranging from $22.41 to $22.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |